PRESENT IN THE X BRAZILIAN STD ASSOCIATION CONFERENCE AND IN THE VI BRAZILIAN AIDS CONFERENCE

05/21/2015 - By Blanver

Notícia-21-292x300Blanver Pharma is located in the city of Taboão da Serra, where manufactures its own finished dosage formulations for HIV, Hepatitis and Osteoporosis treatment. With a high investment in R&D, currently we have three registered medications, and over ten ongoing projects. Blanver Pharma has a high manufacturing quality standard, besides having a Pharmacovigilance Integrated Global System, that gives support to our medications anywhere in the world.

In order to reinforce our Blanver Pharma brand and our commitment to patients’ quality of life, this year we participated in the X Brazilian STD Association Conference and in the VI Brazilian AIDS Conference, that took place in São Paulo on May 17-20, 2015.

Blanver is committed to patients’ quality of life, as we are one of the manufacturers of antiretrovirals distributed by the SUS (Sistema Único de Saúde – Brazilian Universal Healthcare System).

Currently, our finished dosage formulations are distributed to Brazilian government official laboratories and to SUS, but we are working to expand this area of our business to the world, through alliances and partnerships.